Glycoprotein Ibα clustering induces macrophage-mediated platelet clearance in the liver

Summary

Many immune thrombocytopenia (ITP) patients, particularly patients with anti-glycoprotein (GP) Ib-IX autoantibodies, do not respond to the conventional treatments such as splenectomy. However, the underlying mechanism remains unclear. Here we found that anti-GPIbα N-terminus antibody AN51, but not other anti-GPIbα antibodies (AK2, HIP1, VM16d, or WM23), induced GPIbα clustering that led to integrin αIIbβ3-dependent platelet aggregation. After intravenous injection, AN51 dose-dependently induced thrombocytopenia in guinea pigs, and the platelets were mainly removed by macrophages in the liver. N-acetyl-D-glucosamine, previously shown to inhibit integrin αMβ2-mediated phagocytosis of refrigerated platelets, dose-dependently inhibited AN51-induced platelet clearance. Furthermore, AN51 but not VM16d, induced rapid platelet clearance in the liver of cynomolgus macaques. Five of 22 chronic ITP patients had anti-GPIbα autoantibodies, and the autoantibodies from four of the five patients competed with AN51 for binding to platelets. These data indicate that GPIbα clustering induced by anti-GPIbα N-terminus antibody causes integrin αIIbβ3-dependent platelet aggregation, phagocytosis, and rapid platelet clearance in the liver. Our findings reveal a novel Fc-independent mechanism underlying the pathogenesis of ITP, and suggest new therapeutic strategies for ITP patients with anti-GPIbα autoantibodies.

Keywords

Antibodies - platelets - immune thrombocytopenia - macrophages - glycoprotein Ib-IX

^* R. Y. and M. C. contributed equally to this work.

• References

• 1 Neunert C, Lim W, Crowther M. et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190-4207.
• 2 Stasi R, Evangelista ML, Stipa E. et al. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thromb Haemost 2008; 99: 4-13.
• 3 Louwes H, Zeinali Lathori OA, Vellenga E. et al. Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura. Am J Med 1999; 106: 430-434.
• 4 Webster ML, Sayeh E, Crow M. et al. Relative efficacy of intravenous immunog-lobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIblIIa versus GPIbalpha antibodies. Blood 2006; 108: 943-946.
• 5 McMillan R, Wang L, Tani P. Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP). J Thromb Haemost 2003; 01: 485-491.
• 6 Andrews RK, Gardiner EE, Shen Y. et al. Glycoprotein Ib-IX-V Int. J Biochem Cell Biol 2003; 35: 1170-1174.
• 7 Li R, Emsley J. The organizing principle of the platelet glycoprotein Ib-IX-V complex. J Thromb Haemost 2013; 11: 605-614.
• 8 Li Z, Delaney MK, O’Brien KA. et al. Signalling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 2010; 30: 2341-2349.
• 9 Dai K, Bodnar R, Berndt MC. et al. A critical role for 14-3-3zeta protein in regulating the VWF binding function of platelet glycoprotein Ib-IX and its therapeutic implications. Blood 2005; 106: 1975-1981.
• 10 Beardsley DS, Ertem M. Platelet autoantibodies in immune thrombocytopenic purpura. Transfus Sci 1998; 19: 237-244.
• 11 Ruan C, Tobelem G, McMichael AJ. et al. Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function. Br J Haematol 1981; 49: 511-519.
• 12 Yanabu M, Ozaki Y, Nomura S. et al. Tyrosine phosphorylation and p72syk activation by an anti-glycoprotein Ib monoclonal antibody. Blood 1997; 89: 1590-1598.
• 13 Becker BH, Miller JL. Effects of an antiplatelet glycoprotein Ib antibody on he-mostatic function in the guinea pig. Blood 1989; 74: 690-694.
• 14 Cadroy Y, Hanson SR, Kelly AB. et al. Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates. Blood 1994; 83: 3218-3224.
• 15 Bergmeier W, Rackebrandt K, Schröder W. et al. Structural and functional characterisation of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies. Blood 2000; 95: 886-893.
• 16 Ruan CG, Du XP, Xi XD. et al. A murine antiglycoprotein Ib complex monoclonal antibody, SZ 2, inhibits platelet aggregation induced by both ristocetin and collagen. Blood 1987; 69: 570-577.
• 17 Du X, Beutler L, Ruan C. et al. Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane. Blood 1987; 69: 1524-1527.
• 18 Ruan CG. Monoclonal antibody SZ-21 to platelet membrane glycoprotein IIIa. Chin Med 1987; 67: 76-78.
• 19 Du X, Fox JE, Pei S. Identifcation of a binding sequence for the 14-3-3 protein within the cytoplasmic domain of the adhesion receptor, platelet glycoprotein Iba. J Biol Chem 1996; 271: 7362-7367.
• 20 Dai K, Wang Y, Yan R. et al. Effects of microgravity and hypergravity on platelet functions. Thromb Haemost 2009; 101: 902-910.
• 21 Hoffmeister KM, Felbinger TW, Falet H. et al. The clearance mechanism of chilled blood platelets. Cell 2003; 112: 87-97.
• 22 Hoffmeister KM, Josefsson EC, Isaac NA. et al. Glycosylation restores survival of chilled blood platelets. Science 2003; 301: 1531-1534.
• 23 Rumjantseva V, Grewal PK, Wandall HH. et al. Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat Med 2009; 15: 1273-1280.
• 24 Jansen AJ, Josefsson EC, Rumjantseva V. et al. Desialylation accelerates platelet clearance after refrigeration and initiates GPIba metalloproteinase-mediated cleavage in mice. Blood 2012; 119: 1263-1273.
• 25 Miura S, Sakurai Y, Takatsuka H. et al. Total inhibition of high shear stress induced platelet aggregation by homodimeric von Willebrand factor A1-loop fragments. Br J Haematol 1999; 105: 1092-1100.